（文章来源：证券时报网） 佳合科技 | 301501 | 恒鑫生活 | 78.88 | 35.12 | -6.79 | | --- | --- | --- | --- | --- | | 603014 | C威高 | 37.11 | 34.65 | -4.53 | | 688755 | C汉邦 | 46.83 | 34.54 | -4.82 | | 920068 | 天工股份 | 20.90 | 33.73 | -7.11 | | 870299 | 灿能电力 | 23.78 | 33.65 | -5.63 | | 001206 | 依依股份 | 24.35 | 33.46 | 6.15 | | 300040 | 九洲集团 | 8.10 | 33.26 | -4.48 | | 301488 | 豪恩汽电 | 76.00 | 32.75 | -2.25 | | 600610 | 中毅达 | 15.79 | 32.63 | -5.11 | | 300703 | 创源股份 | 18.58 | 32.49 | -2.31 | | 837023 | 芭薇股份 | 29.28 | 32.19 | -4.38 | | 301 ...

Market Overview - The Sci-Tech Innovation Board (科创板) index rose by 0.24%, closing at 997.68 points, with a total trading volume of 2.228 billion shares and a turnover of 72.896 billion yuan, resulting in a weighted average turnover rate of 1.32% [1] - Among the tradable stocks on the Sci-Tech Innovation Board, 407 stocks closed higher, with 7 stocks increasing by over 10% and 24 stocks rising between 5% and 10%. Conversely, 175 stocks closed lower [1] Stock Performance - The highest turnover rate was recorded by C Hanbang, a newly listed stock, which closed up by 5.69% with a turnover rate of 50.32% and a daily transaction amount of 389 million yuan, attracting a net inflow of 13.6588 million yuan [1] - Other notable stocks with high turnover rates include Aerospace Nanhu, which closed down by 6.42% with a turnover rate of 29.39%, and Liyang Chip, which rose by 15.49% with a turnover rate of 22.58% [1][4] High Turnover Stocks - Among stocks with a turnover rate exceeding 5%, C Hanbang is a newly listed stock. The top gainers included Rongchang Bio, Yifang Bio, and Liyang Chip, with increases of 16.09%, 15.62%, and 15.49%, respectively. The largest decliners were Aerospace Nanhu, Chipsea Technology, and Zhongyan Shares, with declines of 6.42%, 4.52%, and 4.32% [2] - The pharmaceutical and biological industry had the highest representation among high turnover stocks, with 11 stocks listed, followed by electronics and machinery equipment with 7 and 5 stocks, respectively [2] Fund Flow Analysis - In terms of fund flow, 23 stocks with high turnover rates experienced net inflows, with Liyang Chip, Rejing Bio, and Zengxian Electric seeing net inflows of 121 million yuan, 47.0913 million yuan, and 33.5006 million yuan, respectively. Conversely, Aerospace Nanhu, Shijia Photon, and Zhong无人机 experienced significant net outflows of 192 million yuan, 15.55 million yuan, and 9.8762 million yuan [2] - Recent leverage fund movements indicated that 28 stocks had net purchases of leveraged funds, with Aerospace Nanhu, Youfang Technology, and Rongchang Bio seeing the largest increases in financing balances of 82.304 million yuan, 55.5209 million yuan, and 47.9963 million yuan, respectively [3]

Core Viewpoint - C Hanbang (688755) experienced a significant increase of 102.46% on its first trading day, with a turnover rate of 75.65% and a transaction volume of 609 million yuan [2]. Group 1: Company Overview - C Hanbang is a high-tech enterprise focused on chromatography technology, integrating research and development, production, and sales. The company primarily provides professional separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [2]. Group 2: Market Performance - On its debut, C Hanbang's financing buy-in amounted to 49.50 million yuan, accounting for 8.13% of the total trading volume. The latest financing balance stands at 41.76 million yuan, representing 5.48% of the circulating market value [2]. - The stock attracted a net inflow of 210 million yuan from major funds on its first day, with large orders contributing a net inflow of 81.52 million yuan and big orders contributing 129 million yuan [2].

5月16日，在上海证券交易所，伴随着喜庆的开市锣声敲响，江苏汉邦科技股份有限公司成功登陆科创板。作为2025年科创板首家过会的IPO企业，汉邦 科技成为淮安第一家科创板上市公司。 摄影：谭鑫 通讯员：朱海涛 梁锦州 融媒体图片编辑：程钢 张大兵表示，汉邦科技将以此次上市为契机，持续加大研发投入，不断优化产品结构，积极拓展国内外市场渠道，坚定不移地朝着成为全球领先的色谱纯 化解决方案提供商的目标迈进，为中国乃至全球的制药、化工、食品天然产物、医美、新材料等领域贡献更多力量。 汉邦科技公司是淮安一家土生土长的民营企业，经过27年的稳步发展，在液相色谱这一领域深耕细作、勇攀高峰，逐步成长为行业标杆企业。 融媒体记者：唐筱葳 市长顾坤，中信证券股份有限公司高管、全球投资银行管理委员会主任孙毅，汉邦科技公司董事长、总经理张大兵致辞；上海证券交易所数字化专业委员 会副主任兼技术公司董事长张晓京与企业签订《科创板证券上市协议》。省委金融办副主任聂振平，市委常委、常务副市长林小明，市政府秘书长马乃 骏，淮安经开区党工委书记刘爱国共同见证。 顾坤向汉邦科技科创板上市表示祝贺。他说，汉邦科技成功登陆科创板，不仅是企业发展历程中的 ...

Market Overview - The net inflow of main funds in the Shanghai and Shenzhen markets was 307 million yuan, with the Sci-Tech Innovation Board experiencing a net outflow of 512 million yuan [2] - A total of 245 stocks saw net inflows, while 341 stocks experienced net outflows [2] Sci-Tech Innovation Board Performance - On the Sci-Tech Innovation Board, 354 stocks rose and 222 stocks fell today [2] - Newly listed stock C Hanbang closed with a significant increase of 102.46% and a turnover rate of 75.65% [3] Fund Flow Analysis - Among the stocks with net inflows, C Hanbang led with a net inflow of 210 million yuan, followed by Aifute and Hotgen with net inflows of approximately 57.61 million yuan and 47.27 million yuan, respectively [3] - The stock with the highest net outflow was Haiguang Information, which saw a net outflow of 176 million yuan and a decline of 2.43% [2][3] - A total of 49 stocks had continuous net inflows for more than three trading days, with Rui Lian New Materials and Li Yang Chip leading with 10 consecutive days of inflow [3] Key Stocks with Fund Inflows - The top stocks by net inflow include: - C Hanbang: 210.20 million yuan, 34.52% inflow rate, 102.46% increase, 75.65% turnover [3] - Aifute: 57.61 million yuan, 7.81% inflow rate, 1.13% increase, 5.01% turnover [3] - Hotgen: 47.27 million yuan, 7.29% inflow rate, 12.09% increase, 6.60% turnover [3] Key Stocks with Fund Outflows - The stocks with the highest net outflows include: - Haiguang Information: 176 million yuan outflow, 2.43% decrease [2] - Hanwujing: 168 million yuan outflow [2] - Zhongwei Company: 72.16 million yuan outflow [2]

Core Viewpoint - Jiangsu Hanbang Technology Co., Ltd. has successfully listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with a closing price of 46.10 yuan, representing a 102.46% increase on the first day of trading [1] Company Overview - Hanbang Technology focuses on chromatography technology, integrating research and development, production, and sales, primarily serving the pharmaceutical and life sciences sectors with specialized separation and purification equipment, consumables, and technical solutions [1] - The company is controlled by Zhang Dabin, who holds 23.75% of the shares directly and has a total control of 28.94% post-IPO [1] IPO Details - The company issued 22,000,000 shares at a price of 22.77 yuan per share, raising a total of 500.94 million yuan, with a net amount of 430.67 million yuan after deducting issuance costs [4] - The total issuance costs amounted to 70.27 million yuan, with underwriting fees of 37.29 million yuan [6] Financial Performance - For the years 2022 to 2024, the company reported revenues of 481.79 million yuan, 619.01 million yuan, and 690.88 million yuan, respectively, with net profits of 38.56 million yuan, 51.50 million yuan, and 79.34 million yuan [6][7] - In the first quarter of 2025, the company achieved total revenue of 165.23 million yuan, a year-on-year increase of 19.88%, and a net profit of 11.10 million yuan, up 93.79% from the previous year [9][10] Project Funding Allocation - The raised funds will be allocated to three main projects: 1. Annual production of 1,000 units of liquid chromatography separation equipment (19.30 million yuan) 2. Construction of a chromatography separation equipment R&D center (27.11 million yuan) 3. Annual production of 2,000 units of laboratory chromatography separation and purification instruments (22.48 million yuan) [5]

Group 1 - The Sci-Tech 50 Index opened slightly lower on May 16, closing at 995.24 points with a decline of 0.57% and a total trading volume of approximately 17.2 billion [1] - The Sci-Tech Comprehensive Index also opened lower but rose during the day, ultimately closing at 1170.20 points with an increase of 0.12% and a total trading volume of about 71.4 billion [1] - A significant number of stocks on the Sci-Tech Board reached new highs, with 16 stocks hitting their highest levels since 2025, and 36 stocks achieving new highs over the past 30 trading days [1] Group 2 - Hanbang Technology was listed on the Sci-Tech Board on May 16 with a stock code of 688755, and its share price increased by 102.46% on the first day, with a trading volume of approximately 609 million [2] - Excluding Hanbang Technology's first-day performance, the average increase for the remaining 586 stocks on the Sci-Tech Board was 0.70%, with an average turnover rate of 1.97% and a total trading volume of 708.34 billion [2] - In terms of individual stock performance, Hanjing Bio saw the highest increase at 12.09%, while Jingyuan Environmental experienced the largest decline at 9.38% [2] Group 3 - In terms of trading volume, Hanbang Technology led with 2.403 billion, while Conglin Technology had the lowest trading volume at 702.32 million [3] - The turnover rate for Aerospace Nanhu was the highest at 26.68%, while Longteng Optoelectronics had the lowest turnover rate at 0.09% [3]

Company Overview - Jiangsu Hanbang Technology Co., Ltd. was established in 1998 and currently employs over 650 people. It is recognized as a national high-tech enterprise and a "little giant" enterprise specializing in technology [5][8]. - The company focuses on providing professional separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [7]. Market Performance - On May 16, 2023, Hanbang Technology successfully listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with a stock price of 22.77 yuan per share [3]. - On its first trading day, the stock surged by 115.20%, reaching a price of 49 yuan, resulting in a market capitalization of 4.312 billion yuan. The stock price later exceeded 50 yuan, with a rise of over 120% [4]. Innovation and Recognition - The company has a strong commitment to independent innovation, holding a total of 51 authorized invention patents, including 38 domestic and 13 overseas patents [8]. - Hanbang Technology has led or participated in 15 provincial-level or higher scientific research or industrialization projects, including six national-level projects [8]. Industry Position - Hanbang Technology holds a leading market share in the domestic chromatography separation and purification equipment market and aims to become a mainstream provider of overall solutions for global pharmaceutical companies [8]. - The company serves over 2,000 clients, including well-known domestic pharmaceutical enterprises such as Heng Rui Medicine, Zhengda Tianqing, and international clients from countries like Germany, the UK, India, South Korea, and Norway [8].

Company Overview - N Hanbang has been listed today with an opening price of 49.00 yuan, representing an increase of 115.20% from its issue price [2] - The company focuses on chromatography technology, integrating research and development, production, and sales, primarily serving the pharmaceutical and life sciences sectors with specialized separation and purification equipment, consumables, application technology services, and related technical solutions [2] Financial Highlights - The total number of shares issued by the company is 22 million, with an online issuance of 7.04 million shares at an issue price of 22.77 yuan per share [2] - The issue price corresponds to a price-to-earnings (P/E) ratio of 26.35, compared to the industry average P/E ratio of 28.04 [2] - The total funds raised from the initial public offering (IPO) amount to 501 million yuan, which will be used for working capital, the construction of a chromatography separation equipment R&D center, and the production projects for laboratory chromatography separation and purification instruments [2] Recent IPO Performance - N Hanbang's first-day performance is notable, with a significant increase of 115.20% [2] - Other recent IPOs on the same day include N Zairun, which saw a rise of 98.12%, and Tian Gong Co., which experienced a dramatic increase of 458.63% [3]

Core Viewpoint - Hanbang Technology has successfully transitioned from a chromatography consumables agent to a leading domestic manufacturer of preparative chromatography equipment, becoming the first stock of chromatography equipment on the Sci-Tech Innovation Board [3][4]. Company Development - Established in 1998, Hanbang Technology initially focused on the agency sales of chromatography consumables, facing market saturation by 2006, which prompted a shift towards independent research and development [4]. - The company launched its first dynamic axial compression column in 2005, and by 2012, revenue from self-developed products surpassed that from agency sales [4][5]. - By 2024, Hanbang Technology was recognized as a "little giant" enterprise by the Ministry of Industry and Information Technology, ranking first in the domestic production-grade small molecule liquid chromatography system market [5]. Talent and R&D - Since 2010, Hanbang Technology has focused on attracting and retaining R&D talent, forming a technical team of 141 members by 2024, including 5 core technical personnel [5]. - The company implements various incentive measures, such as salary bonuses and stock options, to stabilize and develop its core technical team [5]. Market Position and Clientele - Hanbang Technology primarily serves the pharmaceutical industry, with notable clients including domestic giants like Heng Rui Medicine and international pharmaceutical equipment integrators [6][7]. - The company emphasizes the importance of high-purity separation and purification technologies, which are increasingly demanded due to stringent regulatory requirements [7]. Business Model and Solutions - Hanbang Technology adopts a dual approach of product development and customized turnkey services, offering solutions for both small and large molecule drug separation and purification [7]. - The company provides tailored solutions based on client sample characteristics, optimizing chromatography filler performance to reduce production costs [7]. Financial Performance - The company's revenue has shown consistent growth, with figures of 482 million yuan, 619 million yuan, and 691 million yuan from 2022 to 2024, respectively [8]. - Net profit attributable to the parent company has also increased, reaching approximately 79.34 million yuan in 2024 [8]. Future Outlook - Hanbang Technology anticipates continued growth in the domestic liquid chromatography market, with the laboratory liquid chromatography market projected to reach 3.6 billion yuan by 2026 [8]. - The company plans to raise funds through an IPO to enhance production capacity and R&D capabilities, with specific projects aimed at increasing production of chromatography equipment and laboratory instruments [8][9]. - Future technical focuses include optimizing chromatography system pressure resistance, fluid distribution, sealing, and homogenization technologies, as well as developing higher selectivity chromatography materials [9].